Asociacion Espanola de Hematologia y Hemoterapia
1 clinical trials · Sponsor
◉ Watch Asociacion Espanola de Hematologia y Hemoterapia
| Record | Firm | Date |
|---|---|---|
| Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma (NCT01124526) | Asociacion Espanola de Hematologia y Hemoterapia | 2004-09-01 |
Track Asociacion Espanola de Hematologia y Hemoterapia automatically
Every clearance here is in the API, with alerts when new ones post.